Warning: The NCBI web site requires JavaScript to function. more...
Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease?
Farlow MR.
Alzheimers Res Ther. 2010 Jun 8;2(3):15.
Related citations
Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4.
Olichney JM, Hansen LA, Hofstetter CR, Lee JH, Katzman R, Thal LJ.
Arch Neurol. 2000 Jun;57(6):869-74.
Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
Richey PL, Siedlak SL, Smith MA, Perry G.
Biochem Biophys Res Commun. 1995 Mar 17;208(2):657-63.
Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.
Arch Neurol. 2005 Jun;62(6):975-80.
Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M, Yu GQ, Shockley K, Huang Y, Jones B, Masliah E, Mallory M, Yeo T, Longo FM, Mucke L.
J Neurosci. 2002 Dec 15;22(24):10539-48.
Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.
Ohm TG, Scharnagl H, März W, Bohl J.
Acta Neuropathol. 1999 Sep;98(3):273-80.
Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.
Lippa CF, Smith TW, Saunders AM, Hulette C, Pulaski-Salo D, Roses AD.
Neurology. 1997 Feb;48(2):515-9.
Microglial activation in Alzheimer disease: Association with APOE genotype.
Egensperger R, Kösel S, von Eitzen U, Graeber MB.
Brain Pathol. 1998 Jul;8(3):439-47.
Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S, Abraham CR, Zannis VI.
Biochemistry. 1997 Aug 26;36(34):10571-80.
Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease.
Clatworthy AE, Gomez-Isla T, Rebeck GW, Wallace RB, Hyman BT.
Arch Neurol. 1997 Oct;54(10):1289-92.
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD.
Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9649-53.
APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
Fukumoto H, Ingelsson M, Gårevik N, Wahlund LO, Nukina N, Yaguchi Y, Shibata M, Hyman BT, Rebeck GW, Irizarry MC.
Exp Neurol. 2003 Sep;183(1):249-53.
Why lipids are important for Alzheimer disease?
Hirsch-Reinshagen V, Burgess BL, Wellington CL.
Mol Cell Biochem. 2009 Jun;326(1-2):121-9. Epub 2008 Dec 31.
Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.
Am J Pathol. 1996 Jun;148(6):2083-95.
Apolipoprotein E genotype and gender influence response to tacrine therapy.
Farlow MR, Lahiri DK, Poirier J, Davignon J, Hui S.
Ann N Y Acad Sci. 1996 Dec 16;802:101-10.
Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer's disease.
Refolo LM, Fillit HM.
J Mol Neurosci. 2004;23(3):151-5. Review.
Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
Pahnke J, Walker LC, Schroeder E, Vogelgesang S, Stausske D, Walther R, Warzok RW.
Acta Neuropathol. 2003 Jan;105(1):25-9. Epub 2002 Nov 5.
ApoE genotype accounts for the vast majority of AD risk and AD pathology.
Raber J, Huang Y, Ashford JW.
Neurobiol Aging. 2004 May-Jun;25(5):641-50. Review.
The effect of apolipoprotein E genotype on expression of an autosomal dominant schizophreniform disorder with progressive dementia and neurofibrillary tangles.
Tsuang D, Raskind MA, Leverenz J, Peskind ER, Schellenberg G, Bird TD.
Biol Psychiatry. 1997 Jan 15;41(2):191-5.
Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent.
Beffert U, Cohn JS, Petit-Turcotte C, Tremblay M, Aumont N, Ramassamy C, Davignon J, Poirier J.
Brain Res. 1999 Oct 2;843(1-2):87-94.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on